RxDoctor Payments Data

Robert Klausner, MD

Otolaryngology/Facial Plastic Surgery · Bonita Springs, FLNPI 1134156771

Payments from drug & device makers

What this record shows

Intersect ENT, Inc. accounts for 69.4% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $2,724 and has fallen 95.3% since, to $127 in 2025.

$3,750in general payments, 2019–2025

Across 20 payments — averaging $187.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intersect ENT, Inc.$3K
  • Optinose US, Inc.$627
  • Stryker$298
  • Medtronic$202
  • Ambu Inc.$21

What the payments were for

  • Travel & lodging$1,75047%
  • Food & beverage$2,00053%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Intersect ENT, Inc.11$2,602
Optinose US, Inc.5$627
Stryker2$298
Medtronic1$202
Ambu Inc.1$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,750 in reported general payments places this provider in the 65th percentile of 48 otolaryngology/facial plastic surgery providers in Florida.

See all otolaryngology/facial plastic surgery providers in Florida

Medicare billing

Part B allowed, 2024
$377,058
Medicare patients
598
Services billed
3,038

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tobramycin-DexamethasoneTobramycin/Dexamethasone99$7,298
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth20$2,185
Azelastine Hcl57$1,770
Fluticasone Propionate68$1,740
Fluocinolone AcetonideFluocinolone/Shower Cap30$1,453
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav99$1,063
Ipratropium Bromide19$952
Clotrimazole22$471
Prednisone108$451
Doxycycline Hyclate34$409
Omeprazole13$216
Mupirocin21$174
Famotidine26$141
Methylprednisolone20$122
Cephalexin11$85

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Bonita Springs

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →